U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H24FN3O2
Molecular Weight 405.4647
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ADOPRAZINE

SMILES

FC1=CC=C(C=C1)C2=CN=CC(CN3CCN(CC3)C4=CC=CC5=C4OCCO5)=C2

InChI

InChIKey=IUVSEUFHPNITEQ-UHFFFAOYSA-N
InChI=1S/C24H24FN3O2/c25-21-6-4-19(5-7-21)20-14-18(15-26-16-20)17-27-8-10-28(11-9-27)22-2-1-3-23-24(22)30-13-12-29-23/h1-7,14-16H,8-13,17H2

HIDE SMILES / InChI

Molecular Formula C24H24FN3O2
Molecular Weight 405.4647
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.solvay.com/en/binaries/20080930_Pharma-135290.pdf

Adoprazine (SVL-313) is a full 5-HT1A receptor agonist and full D2/3 receptor antagonist possessing characteristics of an atypical antipsychotic, representing a potential novel treatment for schizophrenia and bipolar disorder. This drug together with some others, e.g. Mazapertine succinate, PF-217830 was discontinued from clinical trials due to either non-optimal pharmacokinetic properties or insufficient therapeutical efficacy.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
9.0 null [pEC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG



OverviewOther

Other InhibitorOther SubstrateOther Inducer

Drug as perpetrator​

Drug as perpetrator​

Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
no
PubMed

PubMed

TitleDatePubMed
Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
2005 Aug
SAR study of 1-aryl-4-(phenylarylmethyl)piperazines as ligands for both dopamine D2 and serotonin 5-HT1A receptors showing varying degrees of (Ant)agonism. Selection of a potential atypical antipsychotic.
2006 Sep
SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
2007 Jan
Patents

Patents

Sample Use Guides

ablets taken once daily for 14 days
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: SLV313 (ADOPRAZINE) possessed high affinity at human recombinant D(2), D(3), D(4), 5-HT(2B), and 5-HT(1A) receptors, moderate affinity at 5-HT(7) and weak affinity at 5-HT(2A) receptors, with little-no affinity at 5-HT(4), 5-HT(6), alpha(1), and alpha(2) (rat), H(1) (guinea pig), M(1), M(4), 5-HT(3) receptors, and the 5-HT transporter. SLV313 had full agonist activity at cloned h5-HT(1A) receptors (pEC(50)=9.0) and full antagonist activity at hD(2) (pA(2)=9.3) and hD(3) (pA(2)=8.9) receptors.
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:10:36 GMT 2023
Edited
by admin
on Fri Dec 15 16:10:36 GMT 2023
Record UNII
7SNB18Q89D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ADOPRAZINE
INN   WHO-DD  
INN  
Official Name English
1-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)-4-((5-(4-FLUOROPHENYL)PYRIDIN-3-YL)METHYL)PIPERAZINE
Systematic Name English
Adoprazine [WHO-DD]
Common Name English
adoprazine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C265
Created by admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
Code System Code Type Description
FDA UNII
7SNB18Q89D
Created by admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
PRIMARY
SMS_ID
300000037041
Created by admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
PRIMARY
INN
8980
Created by admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
PRIMARY
PUBCHEM
9887537
Created by admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
PRIMARY
CAS
222551-17-9
Created by admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
PRIMARY
EPA CompTox
DTXSID40944914
Created by admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
PRIMARY
NCI_THESAURUS
C81482
Created by admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
TARGET -> AGONIST
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY